Literature DB >> 24512365

Retinal Structure in Cobalamin C Disease: Mechanistic and Therapeutic Implications.

Tomas S Aleman1, Frank Brodie1, Christopher Garvin2, Dina Y Gewaily1, Can H Ficicioglu3, Monte D Mills2, Brian J Forbes2, Albert M Maguire1,2, Stefanie L Davidson2.   

Abstract

PURPOSE: To describe the retinal structure in a patient with cobalamin C (cblC) disease.
METHODS: A 13-year-old male patient diagnosed with cblC disease during a perinatal metabolic screening prompted by jaundice and hypotony underwent ophthalmic examinations, electroretinography (ERG) and spectral domain optical coherence tomography (SD-OCT).
RESULTS: The patient carried a homozygous (c.271dupA) mutation in the methylmalonic aciduria and homocystinuria type C (MMACHC) gene. At age 3 months he had a normal eye exam. A pigmentary maculopathy progressed to chorioretinal atrophy from 5-10 months. ERG at 7 months was normal. A nystagmus remained stable since the age of 2 years. At age 13, visual acuity was 20/250 (right eye) and 20/400 (left eye), with a +5.00 D correction, a level of vision maintained since first measurable at age 5 years. SD-OCT showed bilateral macular coloboma-like lesions; there was also a thickened surface layer with ganglion cell layer thinning. Photoreceptor outer segment loss and thinning of the outer nuclear layer (ONL) transitioned to regions with no discernible ONL with a delaminated, thickened, inner retina.
CONCLUSIONS: A thick surface layer near the optic nerve resembling an immature retina and an initially normal macula that rapidly developed coloboma-like lesions suggest there may be an interference with retinal/foveal development in cblC, a mechanism of maculopathy that may be shared by other early onset retinal degenerations. Photoreceptor loss and inner retinal remodeling confirm associated photoreceptor degeneration.

Entities:  

Keywords:  Cobalamin C; coloboma; optical coherence tomography; photoreceptors

Mesh:

Substances:

Year:  2014        PMID: 24512365     DOI: 10.3109/13816810.2014.885059

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  Cobalamin C Disease Missed by Newborn Screening in a Patient with Low Carnitine Level.

Authors:  Rebecca C Ahrens-Nicklas; Esra Serdaroglu; Colleen Muraresku; Can Ficicioglu
Journal:  JIMD Rep       Date:  2015-03-13

Review 2.  Ocular manifestations in patients with inborn errors of intracellular cobalamin metabolism: a systematic review.

Authors:  Karim Matmat; Rosa-Maria Guéant-Rodriguez; Abderrahim Oussalah; Arnaud Wiedemann-Fodé; Carlo Dionisi-Vici; David Coelho; Jean-Louis Guéant; Jean-Baptiste Conart
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 5.881

3.  Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss.

Authors:  Lucas Bonafede; Can H Ficicioglu; Leona Serrano; Grace Han; Jessica I W Morgan; Monte D Mills; Brian J Forbes; Stefanie L Davidson; Gil Binenbaum; Paige B Kaplan; Charles W Nichols; Patrick Verloo; Bart P Leroy; Albert M Maguire; Tomas S Aleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 4.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

5.  Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency.

Authors:  Brian P Brooks; Amy H Thompson; Jennifer L Sloan; Irini Manoli; Nuria Carrillo-Carrasco; Wadih M Zein; Charles P Venditti
Journal:  Ophthalmology       Date:  2016-01-26       Impact factor: 12.079

6.  Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis.

Authors:  Arnaud Wiedemann; Abderrahim Oussalah; Nathalie Lamireau; Maurane Théron; Melissa Julien; Jean-Philippe Mergnac; Baptiste Augay; Pauline Deniaud; Tom Alix; Marine Frayssinoux; François Feillet; Jean-Louis Guéant
Journal:  Cell Rep Med       Date:  2022-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.